U.S. federal trademark · Serial No. 98347437
Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely, pharmaceutical research and development
Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of diabetes; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of diabetes
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.